1 | rapid | 10,411 |
2 | gradual | 953 |
3 | quick | 624 |
4 | swift | 60 |
5 | sluggish | 28 |
6 | speedy | 24 |
7 | precipitous | 22 |
8 | inexorable | 12 |
9 | multifollicular | 10 |
10 | gelatin-based | 9 |
11 | sub-rpe | 9 |
12 | multifoci | 8 |
13 | 3h-thymidine | 7 |
14 | metal-dependent | 7 |
15 | weighted-average | 6 |
16 | auditory-motor | 5 |
17 | bioproduct | 5 |
18 | patient-cooperative | 5 |
19 | postcolumn | 5 |
20 | c9orf72 | 4 |
21 | researcher-designed | 4 |
22 | 125i-fibrinogen | 3 |
23 | 3-phenylpropanoid | 3 |
24 | actin-driven | 3 |
25 | agronomical | 3 |
26 | calcein/pi | 3 |
27 | ceraform | 3 |
28 | clinico-histological | 3 |
29 | dual-step | 3 |
30 | mu-induced | 3 |
31 | multi-analyte | 3 |
32 | photophysiological | 3 |
33 | post-bos | 3 |
34 | scar-mediated | 3 |
35 | 150-μg | 2 |
36 | 24-48-hour | 2 |
37 | 35s-sulfate | 2 |
38 | 5-bromo-2'-deoxy-uridine | 2 |
39 | angiogenesis-induced | 2 |
40 | boussinesq | 2 |
41 | busulfan-based | 2 |
42 | calm-mood | 2 |
43 | cue-dependent | 2 |
44 | cyanide-insensitive | 2 |
45 | dual-sugar | 2 |
46 | ellipsoid-like | 2 |
47 | extrapolative | 2 |
48 | haematogenic | 2 |
49 | hydronic | 2 |
50 | hz-rash | 2 |
51 | lidocaine-remifentanil-propofol | 2 |
52 | mrkad-5 | 2 |
53 | multisugar | 2 |
54 | pioglitazone-mediated | 2 |
55 | postdisturbance | 2 |
56 | spatial-context | 2 |
57 | studywide | 2 |
58 | submerged-coil | 2 |
59 | swifter | 2 |
60 | threshold-contrast | 2 |
61 | tonotopical | 2 |
62 | undeserved | 2 |
63 | uni-gold | 2 |
64 | viroseq | 2 |
65 | water-suppressed | 2 |
66 | 2.59/0.1 | 1 |
67 | 3h-proline | 1 |
68 | 50-mm-diameter | 1 |
69 | alvac-aidsvax | 1 |
70 | cancer-oriented | 1 |
71 | conveyor-belt | 1 |
72 | dipping-freezing-fast | 1 |
73 | docetaxel-dependent | 1 |
74 | downfield-shifted | 1 |
75 | early-protected | 1 |
76 | env-pseudotyped | 1 |
77 | erase-stress-a | 1 |
78 | evoked-response | 1 |
79 | fibroblast/myofibroblast | 1 |
80 | fixed-scheduled | 1 |
81 | free-anesthesia | 1 |
82 | fronto-central-parietal | 1 |
83 | grp-r. | 1 |
84 | heterosexist | 1 |
85 | high-risk/early | 1 |
86 | integron-encoded | 1 |
87 | introvenal | 1 |
88 | late-infantile | 1 |
89 | light-to-medium | 1 |
90 | light-up | 1 |
91 | locally-adapted | 1 |
92 | low-magnification | 1 |
93 | mctdh | 1 |
94 | msm-specific | 1 |
95 | nonbortezomib-containing | 1 |
96 | o/s-chemoselective | 1 |
97 | once-through | 1 |
98 | orasure | 1 |
99 | pagnini-mcclure | 1 |
100 | pcr-ligase | 1 |
101 | pda/fda | 1 |
102 | peroxide-free | 1 |
103 | post-assembly | 1 |
104 | post-machining | 1 |
105 | pre-hire | 1 |
106 | rds-adjusted | 1 |
107 | recent/new | 1 |
108 | receptor-captured | 1 |
109 | sahwira | 1 |
110 | sevoflurane/n2o/oxygen | 1 |
111 | standards-compliant | 1 |
112 | sub-millinewton | 1 |
113 | subacute/insidious | 1 |
114 | tf-first | 1 |
115 | tyrosine-mutant | 1 |
116 | uncapped/nonpolyadenylated | 1 |
117 | u‑shaped | 1 |
118 | v-raf-leukaemia | 1 |
119 | water-flow | 1 |
120 | well-linear | 1 |
121 | wheelchair-pedestrian | 1 |
122 | zambia-uab | 1 |
1 | 125i-fibrinogen | 3 |
2 | 150-μg | 2 |
3 | 2.59/0.1 | 1 |
4 | 24-48-hour | 2 |
5 | 3-phenylpropanoid | 3 |
6 | 35s-sulfate | 2 |
7 | 3h-proline | 1 |
8 | 3h-thymidine | 7 |
9 | 5-bromo-2'-deoxy-uridine | 2 |
10 | 50-mm-diameter | 1 |
11 | actin-driven | 3 |
12 | agronomical | 3 |
13 | alvac-aidsvax | 1 |
14 | angiogenesis-induced | 2 |
15 | auditory-motor | 5 |
16 | bioproduct | 5 |
17 | boussinesq | 2 |
18 | busulfan-based | 2 |
19 | c9orf72 | 4 |
20 | calcein/pi | 3 |
21 | calm-mood | 2 |
22 | cancer-oriented | 1 |
23 | ceraform | 3 |
24 | clinico-histological | 3 |
25 | conveyor-belt | 1 |
26 | cue-dependent | 2 |
27 | cyanide-insensitive | 2 |
28 | dipping-freezing-fast | 1 |
29 | docetaxel-dependent | 1 |
30 | downfield-shifted | 1 |
31 | dual-step | 3 |
32 | dual-sugar | 2 |
33 | early-protected | 1 |
34 | ellipsoid-like | 2 |
35 | env-pseudotyped | 1 |
36 | erase-stress-a | 1 |
37 | evoked-response | 1 |
38 | extrapolative | 2 |
39 | fibroblast/myofibroblast | 1 |
40 | fixed-scheduled | 1 |
41 | free-anesthesia | 1 |
42 | fronto-central-parietal | 1 |
43 | gelatin-based | 9 |
44 | gradual | 953 |
45 | grp-r. | 1 |
46 | haematogenic | 2 |
47 | heterosexist | 1 |
48 | high-risk/early | 1 |
49 | hydronic | 2 |
50 | hz-rash | 2 |
51 | inexorable | 12 |
52 | integron-encoded | 1 |
53 | introvenal | 1 |
54 | late-infantile | 1 |
55 | lidocaine-remifentanil-propofol | 2 |
56 | light-to-medium | 1 |
57 | light-up | 1 |
58 | locally-adapted | 1 |
59 | low-magnification | 1 |
60 | mctdh | 1 |
61 | metal-dependent | 7 |
62 | mrkad-5 | 2 |
63 | msm-specific | 1 |
64 | mu-induced | 3 |
65 | multi-analyte | 3 |
66 | multifoci | 8 |
67 | multifollicular | 10 |
68 | multisugar | 2 |
69 | nonbortezomib-containing | 1 |
70 | o/s-chemoselective | 1 |
71 | once-through | 1 |
72 | orasure | 1 |
73 | pagnini-mcclure | 1 |
74 | patient-cooperative | 5 |
75 | pcr-ligase | 1 |
76 | pda/fda | 1 |
77 | peroxide-free | 1 |
78 | photophysiological | 3 |
79 | pioglitazone-mediated | 2 |
80 | post-assembly | 1 |
81 | post-bos | 3 |
82 | post-machining | 1 |
83 | postcolumn | 5 |
84 | postdisturbance | 2 |
85 | pre-hire | 1 |
86 | precipitous | 22 |
87 | quick | 624 |
88 | rapid | 10,411 |
89 | rds-adjusted | 1 |
90 | recent/new | 1 |
91 | receptor-captured | 1 |
92 | researcher-designed | 4 |
93 | sahwira | 1 |
94 | scar-mediated | 3 |
95 | sevoflurane/n2o/oxygen | 1 |
96 | sluggish | 28 |
97 | spatial-context | 2 |
98 | speedy | 24 |
99 | standards-compliant | 1 |
100 | studywide | 2 |
101 | sub-millinewton | 1 |
102 | sub-rpe | 9 |
103 | subacute/insidious | 1 |
104 | submerged-coil | 2 |
105 | swift | 60 |
106 | swifter | 2 |
107 | tf-first | 1 |
108 | threshold-contrast | 2 |
109 | tonotopical | 2 |
110 | tyrosine-mutant | 1 |
111 | uncapped/nonpolyadenylated | 1 |
112 | undeserved | 2 |
113 | uni-gold | 2 |
114 | u‑shaped | 1 |
115 | v-raf-leukaemia | 1 |
116 | viroseq | 2 |
117 | water-flow | 1 |
118 | water-suppressed | 2 |
119 | weighted-average | 6 |
120 | well-linear | 1 |
121 | wheelchair-pedestrian | 1 |
122 | zambia-uab | 1 |
1 | grp-r. | 1 |
2 | 2.59/0.1 | 1 |
3 | c9orf72 | 4 |
4 | mrkad-5 | 2 |
5 | erase-stress-a | 1 |
6 | pda/fda | 1 |
7 | v-raf-leukaemia | 1 |
8 | free-anesthesia | 1 |
9 | sahwira | 1 |
10 | zambia-uab | 1 |
11 | msm-specific | 1 |
12 | haematogenic | 2 |
13 | hydronic | 2 |
14 | angiogenesis-induced | 2 |
15 | mu-induced | 3 |
16 | integron-encoded | 1 |
17 | fixed-scheduled | 1 |
18 | researcher-designed | 4 |
19 | u‑shaped | 1 |
20 | env-pseudotyped | 1 |
21 | receptor-captured | 1 |
22 | busulfan-based | 2 |
23 | gelatin-based | 9 |
24 | water-suppressed | 2 |
25 | pioglitazone-mediated | 2 |
26 | scar-mediated | 3 |
27 | uncapped/nonpolyadenylated | 1 |
28 | early-protected | 1 |
29 | downfield-shifted | 1 |
30 | cancer-oriented | 1 |
31 | locally-adapted | 1 |
32 | rds-adjusted | 1 |
33 | undeserved | 2 |
34 | 3-phenylpropanoid | 3 |
35 | rapid | 10,411 |
36 | uni-gold | 2 |
37 | calm-mood | 2 |
38 | postdisturbance | 2 |
39 | studywide | 2 |
40 | peroxide-free | 1 |
41 | weighted-average | 6 |
42 | ellipsoid-like | 2 |
43 | inexorable | 12 |
44 | late-infantile | 1 |
45 | 3h-thymidine | 7 |
46 | 5-bromo-2'-deoxy-uridine | 2 |
47 | 3h-proline | 1 |
48 | sub-rpe | 9 |
49 | pre-hire | 1 |
50 | pagnini-mcclure | 1 |
51 | orasure | 1 |
52 | pcr-ligase | 1 |
53 | evoked-response | 1 |
54 | 35s-sulfate | 2 |
55 | multi-analyte | 3 |
56 | extrapolative | 2 |
57 | patient-cooperative | 5 |
58 | o/s-chemoselective | 1 |
59 | cyanide-insensitive | 2 |
60 | nonbortezomib-containing | 1 |
61 | post-machining | 1 |
62 | 150-μg | 2 |
63 | mctdh | 1 |
64 | once-through | 1 |
65 | hz-rash | 2 |
66 | sluggish | 28 |
67 | multifoci | 8 |
68 | calcein/pi | 3 |
69 | quick | 624 |
70 | photophysiological | 3 |
71 | clinico-histological | 3 |
72 | agronomical | 3 |
73 | tonotopical | 2 |
74 | introvenal | 1 |
75 | fronto-central-parietal | 1 |
76 | gradual | 953 |
77 | submerged-coil | 2 |
78 | lidocaine-remifentanil-propofol | 2 |
79 | ceraform | 3 |
80 | light-to-medium | 1 |
81 | wheelchair-pedestrian | 1 |
82 | 125i-fibrinogen | 3 |
83 | sevoflurane/n2o/oxygen | 1 |
84 | actin-driven | 3 |
85 | postcolumn | 5 |
86 | low-magnification | 1 |
87 | sub-millinewton | 1 |
88 | dual-step | 3 |
89 | light-up | 1 |
90 | viroseq | 2 |
91 | boussinesq | 2 |
92 | well-linear | 1 |
93 | dual-sugar | 2 |
94 | multisugar | 2 |
95 | multifollicular | 10 |
96 | 50-mm-diameter | 1 |
97 | swifter | 2 |
98 | auditory-motor | 5 |
99 | 24-48-hour | 2 |
100 | post-bos | 3 |
101 | subacute/insidious | 1 |
102 | precipitous | 22 |
103 | bioproduct | 5 |
104 | swift | 60 |
105 | conveyor-belt | 1 |
106 | standards-compliant | 1 |
107 | tyrosine-mutant | 1 |
108 | cue-dependent | 2 |
109 | metal-dependent | 7 |
110 | docetaxel-dependent | 1 |
111 | dipping-freezing-fast | 1 |
112 | fibroblast/myofibroblast | 1 |
113 | threshold-contrast | 2 |
114 | heterosexist | 1 |
115 | tf-first | 1 |
116 | spatial-context | 2 |
117 | recent/new | 1 |
118 | water-flow | 1 |
119 | alvac-aidsvax | 1 |
120 | speedy | 24 |
121 | post-assembly | 1 |
122 | high-risk/early | 1 |